Sinolinks Medical Innovation Inc., founded in 2004, has good ability on R&D and production, base in the field ofsurgical consumables. Except the strong R&D capabilities, Sinolinks has acquired 51 patents, including 12 inventionpatents. In terms of production, it has a 100,000-levelclean room of 1,500 square meters.A two-stage reverse osmosis purified water system, an oil-free anhydrous air system and a constant temperatureand humidity warehouse of 1,500 square meters. Currently, Sinolinks obtains CFDA, CE and FDA certificate. Sinolinkshas nearly 1,000 domestic customers, and overseas customers ranged in Europe, America and Asia. In the year 2018, Sinolinks become the member of Anrei Group, who is the CBC Group wholly-owned subsidiary.CBC group is a healthcare-dedicated private equity firm that mainly invests in mature, leading businesses across China's major healthcare sectores including pharmaceutical/biotech, medical technology and healthcare services.